Effect of the Gastrointestinal Prokinetic Agent Erythromycin on the Pharmacokinetics of Pregabalin Controlled-Release in Healthy Individuals: A Phase I, Randomized Crossover Trial

Pharmacokinetics of Pregabalin Controlled-Release in Healthy Volunteers: Effect of Food in Five Single-Dose, Randomized, Clinical Pharmacology Studies

(2014) Marci L. Chew et al.   CLINICAL DRUG INVESTIGATION

Pregabalin Controlled-Release Pharmacokinetics in Healthy Volunteers: Analysis of Four Multiple-Dose Randomized Clinical Pharmacology Studies

(2014) Marci L. Chew et al.   CLINICAL DRUG INVESTIGATION

Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study

(2014) Lesley M. Arnold et al.   CURRENT MEDICAL RESEARCH AND OPINION

Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: A double-blind, randomized, placebo-controlled trial

(2014) Jacqueline French et al.   EPILEPSIA

A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain

(2013) Rainer Freynhagen et al.   Pain Practice

Plasma erythromycin concentrations predict feeding outcomes in critically ill patients with feed intolerance*

(2011) Nam Q. Nguyen et al.   CRITICAL CARE MEDICINE

Response of the Human Gastrointestinal Tract to Erythromycin

(2010) Gian-Paolo Zara et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy: Findings from seven randomized, controlled trials across a range of doses

(2008) R. Freeman et al.   DIABETES CARE